Biogen (BIIB)

257.43 -7.57 (2.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/1/21 *Est.)
- Spin-Off (3/31/17 *Est)

Latest Headlines

Stocks with Implied Volatility Movement October 23, 2020 4:19 AM - StreetInsider Biogen (BIIB) PT Raised to $357 at Morgan Stanley October 22, 2020 8:11 AM - StreetInsider Biogen (BIIB) PT Lowered to $350 at Credit Suisse October 22, 2020 5:54 AM - StreetInsider Biogen (BIIB) PT Lowered to $265 at Barclays October 22, 2020 5:42 AM - StreetInsider Stocks with Implied Volatility Movement October 22, 2020 4:51 AM - StreetInsider Form 10-Q BIOGEN INC. For: Sep 30 October 21, 2020 5:18 PM - SEC Filing Biogen (BIIB) PT Lowered to $340 at Oppenheimer October 21, 2020 4:45 PM - StreetInsider Biogen (BIIB) PT Lowered to $258 at Stifel October 21, 2020 4:32 PM - StreetInsider Biogen (BIIB) PT Lowered to $310 at Truist Securities, Following Earnings October 21, 2020 3:54 PM - StreetInsider Form 8-K BIOGEN INC. For: Oct 21 October 21, 2020 7:22 AM - SEC Filing Biogen (BIIB) Tops Q3 EPS by 71c, Updates Guidance, Approves $5 Billion Buyback October 21, 2020 7:05 AM - StreetInsider Abarca Details First Value-Based Agreement For Medicaid Members Prescribed Biogen Products October 20, 2020 11:39 AM - PR NewsWire Biogen (BIIB) October weekly call option implied volatility at 55 into quarter results October 20, 2020 10:06 AM - StreetInsider Biogen (BIIB) PT Lowered to $265 at Piper Sandler October 20, 2020 8:23 AM - StreetInsider Biogen (BIIB) PT Lowered to $268 at RBC Capital After Mock Adcomm October 19, 2020 6:45 AM - StreetInsider Biogen (BIIB) November option implied volatility bid October 16, 2020 4:41 AM - StreetInsider Biogen (BIIB) put call ratio 1.3 calls to 1 put into quarter results and outlook October 15, 2020 1:15 PM - StreetInsider Biogen (BIIB) November IV elevated at 83 October 8, 2020 10:20 AM - StreetInsider Biogen (BIIB) call put ratio 1.3 calls to 1 put October 8, 2020 5:12 AM - StreetInsider Biogen (BIIB) call put ratio 1.2 calls to 1 put October 7, 2020 10:27 AM - StreetInsider Biogen, gene-editing startup Scribe to develop therapies for Lou Gehrig's disease October 6, 2020 10:08 AM - StreetInsider Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases, Including Amyotrophic Lateral Sclerosis October 6, 2020 10:00 AM - BizWire Samsung Bioepis and Biogen (BIIB) Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis October 6, 2020 7:03 AM - StreetInsider Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis® (ranibizumab) October 6, 2020 7:01 AM - StreetInsider Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis® (ranibizumab) October 6, 2020 7:00 AM - Globe NewsWire Biogen (BIIB) November IV bid October 1, 2020 12:12 PM - StreetInsider Biogen (BIIB) option implied volatility increases September 29, 2020 10:37 AM - StreetInsider Biogen (BIIB) January options active into November FDA panel September 29, 2020 3:53 AM - StreetInsider Biogen (BIIB) November option implied volatility elevated September 28, 2020 3:53 PM - StreetInsider Biogen (BIIB) Loses Appeal on Patent Fight Over Rebif MS Drug - Bloomberg September 28, 2020 9:50 AM - StreetInsider FDA Schedules Nov. 6 Panel for Biogen's (BIIB) aducanumab for Alzheimer's September 28, 2020 8:54 AM - StreetInsider Roche Alzheimer's drug fails, joining long list of trial flops September 23, 2020 9:21 AM - StreetInsider Form 8-K BIOGEN INC. For: Sep 15 September 21, 2020 5:16 PM - SEC Filing Biogen's (BIIB) Tecfidera Drop-off Will Be Larger than Expected, PT Lowered to $277 - RBC Capital September 18, 2020 11:49 AM - StreetInsider Biogen (BIIB) Loses Delaware Ruling Over Patent for Tecfidera - Bloomberg September 16, 2020 10:01 AM - StreetInsider Alexion Pharma (ALXN) Spikes on Unconfirmed Market Chatter September 15, 2020 3:20 PM - StreetInsider Biogen to Invest $250 Million in a 20-year Initiative to Eliminate its Use of Fossil Fuels and Improve Public Health September 14, 2020 7:31 AM - StreetInsider Biogen to Invest $250 Million in a 20-year Initiative to Eliminate its Use of Fossil Fuels and Improve Public Health September 14, 2020 7:30 AM - Globe NewsWire Biogen (BIIB) Says New Data at ACTRIMS-ECTRIMS Meeting Showcase Safety and Efficacy of its Industry-Leading MS Portfolio September 11, 2020 8:05 AM - StreetInsider New Data at ACTRIMS-ECTRIMS Meeting Showcase Safety and Efficacy of Biogen’s Industry-Leading MS Portfolio September 11, 2020 8:02 AM - StreetInsider New Data at ACTRIMS-ECTRIMS Meeting Showcase Safety and Efficacy of Biogen’s Industry-Leading MS Portfolio September 11, 2020 8:01 AM - Globe NewsWire New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MS September 8, 2020 7:31 AM - StreetInsider New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MS September 8, 2020 7:30 AM - Globe NewsWire Form 4 BIOGEN INC. For: Sep 01 Filed by: MCDONNELL MICHAEL R September 3, 2020 5:18 PM - SEC Filing OneUnited Bank, Fintech Pioneer, Announces $10 Million Deposit By Biogen To Support #BankBlack Movement September 3, 2020 9:22 AM - PR NewsWire Biogen (BIIB) PT Lowered to $275 at Wolfe Research August 21, 2020 7:46 AM - StreetInsider Form 3 BIOGEN INC. For: Aug 15 Filed by: MCDONNELL MICHAEL R August 20, 2020 4:22 PM - SEC Filing Mylan (MYL) Brings Critical Access to MS Community by Launching More Affordable Treatment Option Through First Generic to Tecfidera August 19, 2020 7:07 AM - StreetInsider Mylan (MYL) Gets FDA Approval for Generic Tecfidera, Biogen (BIIB) Drops to Low - Bloomberg August 18, 2020 3:15 PM - StreetInsider Buffett's Berkshire Hathaway Enters Barrick Gold (GOLD), Raises Kroger (KR), Lowers JP Morgan (JPM), Maintains Apple (AAPL) - 13F August 14, 2020 4:11 PM - StreetInsider Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results August 11, 2020 4:02 PM - StreetInsider Credit Suisse Upgrades Biogen (BIIB) to Outperform, After FDA Related Business Update August 7, 2020 2:57 PM - StreetInsider Biogen (BIIB) Well Positioned After FDA Grants Priority Review - Canaccord Genuity August 7, 2020 12:27 PM - StreetInsider Biogen (BIIB) PT Raised to $360 at Oppenheimer as FDA Accepts Adu BLA with Priority Review August 7, 2020 10:35 AM - StreetInsider Biogen (BIIB) call put ratio 3.3 calls to 1 put after FDA accepts aducanumab with priority review August 7, 2020 10:15 AM - StreetInsider Pre-Open Stock Movers 08/07: (TRUE) (GRPN) (STMP) Higher; (AYX) (DDOG) (ILMN) Lower (more...) August 7, 2020 9:26 AM - StreetInsider Biogen (BIIB) Could Trade Up to ~$350/Share Into FDA Adu Decision - Guggenheim August 7, 2020 8:45 AM - StreetInsider Biogen (BIIB) call put ratio 3.4 calls to 1 put into FDA accepts aducanumab with priority review August 7, 2020 8:08 AM - StreetInsider Biogen (BIIB) Announces FDA Accepts its Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review August 7, 2020 7:32 AM - StreetInsider FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review August 7, 2020 7:31 AM - StreetInsider FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review August 7, 2020 7:30 AM - Globe NewsWire Pre-Open Movers 08/06: (AVCT) (DNLI) (VSTO) Higher; (MVIS) (APRN) (FSLY) Lower (more...) August 6, 2020 9:23 AM - StreetInsider Biogen (BIIB), Denali (DNLI) to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases August 6, 2020 8:09 AM - StreetInsider Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases August 6, 2020 8:03 AM - StreetInsider Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases August 6, 2020 8:02 AM - Globe NewsWire Form 4 BIOGEN INC. For: Jul 31 Filed by: Gregory Ginger August 4, 2020 4:13 PM - SEC Filing Biogen (BIIB) Loses Bid to Block Mylan (MYL) from Selling Tecfidera Copy - Bloomberg July 30, 2020 9:18 AM - StreetInsider Full Article List